MarketsStocksALIVUS
AL

Alivus Life Sciences Ltd

NSE: ALIVUSBSE: 543322Healthcare
Download Research Report7-page PDF
999.00
-3.24%
NSE · auto-updates while market open
Prev Close
₹1,006.10
Day High
₹1,047.00
Day Low
₹996.40
Mkt Cap
₹2,429 Cr
P / E
4.3
P / B
0.7
ROE
18.4%
52W High
₹1,148.40
52W Low
₹819.00
Key Metrics
Market Cap
₹2,429 Cr
P / E
4.30
P / B
0.73
EV / EBITDA
3.28
ROCE
24.6%
ROE
18.4%
Debt / Equity
0.00
Book Value
₹1357.45
EPS
₹45.99
Div Yield
0.5%
Face Value
-
Promoter Holding
74.9%
Revenue · ₹ Cr
2.1k
FY22
2.2k
FY23
2.3k
FY24
2.4k
FY25
2.6k
FY26
Net Profit · ₹ Cr
419
FY22
467
FY23
471
FY24
486
FY25
564
FY26
EPS · ₹ per share
₹35.6
FY22
₹38.1
FY23
₹38.4
FY24
₹39.6
FY25
₹46.0
FY26
P / E Ratio · price ÷ TTM EPS
818283952240-4Mar 22Aug 23Jan 25Jun 26
P/E 21.8×Median 20.6×TTM EPS
Q1 2026 snapshot
Sales
₹712 Cr
Operating profit
-
OPM
-
Net profit
₹163 Cr
EPS
₹13.23
Scorecard · 7 axes
Quality
Strong
78/100
Valuation
Strong
4.3×
Growth
Avg
+6.2%
Profitability
Strong
21.5%
Performance
Weak
+2.1%
Entry Point
Avg
87%
Red Flags
Strong
0 flags
Shareholding Pattern
74.9%Promoter
Promoter74.9%
FII5.3%
DII7.3%
Public12.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue641.844659.63610.83602.7686.82711.89
Net Profit136.96141.868121.535130.026150.261162.661
NPM %21.3%21.5%19.9%21.6%21.9%22.8%
AlertPre-trade